| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT04267913 Details | 2020-11-20 Interventional | 2 | 0 | Antibodies Antibodies, Mon… Antineoplastic … BB 1101 Dexamethasone Dexamethasone a… Docetaxel Immunoglobulins Lexatumumab Ramucirumab Carcinoma Lung Neoplasms Lung Squamous C… Recurrent Lung … Stage IV Lung C… Stage IVA Lung … Stage IVB Lung … | The pharmaceutical company sold the compound and pulled out. - | |||
| NCT01383044 Details | 2020-11-20 Interventional | 4 | 65 | Carvedilol Hemorrhage Variceal Bleedi… | slow enrollment - | |||
| NCT01096290 Details | 2020-11-20 Interventional | 4 | 23 | Lubiprostone Constipation | Number of needed participants could not be obtained 100 participants were needed to obtain statistical power. Only 23 participants were enrolled. Therefore, data analysis was not completed since a success rate could not be adequately demonstrated on such a small sample. | |||
| NCT04343001 Details | 2020-11-19 Interventional | 3 | 0 | Aspirin Losartan Simvastatin COVID-19 Covid-19 | Grant not obtained - | |||
| NCT03962634 Details | 2020-11-19 Interventional | 2 | 3 | Carticaine Oxymetazoline Tetracaine Dental Caries Periapical Peri… Periodontitis Apical Periodon… Caries,Dental | Drug is no longer being manufactured - | |||
| NCT03760250 Details | 2020-11-19 Interventional | 2 | 6 | Imiquimod Keloid Recurrence | Investigator decision - | |||
| NCT03028012 Details | 2020-11-18 Interventional | 4 | 10 | Dexamethasone Ketorolac Lidocaine Myofascial Pain | Poor enrollment. Early termination of this study due to low subject enrollment, lack of participant follow-up to substantiated end of study measures. There was not enough reported data to provide statistically pertinent or relevant analysis. | |||
| NCT02942485 Details | 2020-11-18 Interventional | 4 | 8 | Metronidazole Tinidazole Giardiasis GIARDIASIS | Extremely slow enrollment The study was terminated due to the extremely slow patient enrollment: eight patients only have been referred and recruited during the two-year period. 6/8 patients fulfilled one or more of the exclusion criteria. | |||
| NCT04345692 Details | 2020-11-17 Interventional | 3 | 17 | Hydroxychloroqu… COVID-19 | RECOVERY Trial results - no efficacy - | |||
| NCT04262388 Details | 2020-11-17 Interventional | 2 | 0 | Durvalumab Adenocarcinoma Carcinoma Carcinoma, Non-… Carcinoma, Squa… Lung Neoplasms Squamous Cell C… Non-small Cell … Pancreatic Duct… | Overall clinical activity (ORR) for oleclumab + durvalumab is minimal across tumor types and
does not support further evaluation of this doublet. - | |||
| NCT04262375 Details | 2020-11-17 Interventional | 2 | 0 | Durvalumab Carcinoma, Rena… Non Small Cell … Renal Cell Carc… | Overall clinical activity (ORR) for oleclumab + durvalumab is minimal across tumor types and
does not support further evaluation of this doublet. - | |||
| NCT04138485 2019-000906-31 Details | 2020-11-17 Interventional | 2 | 0 | Immunoglobulins Scleroderma, Di… Scleroderma, Sy… Sclerosis Diffuse Cutaneo… | Due to business reasons, not safety issues - | |||
| NCT02387164 Details | 2020-11-17 Interventional | 2 | 26 | Cholecalciferol Vitamin D Diabetes Mellit… Prediabetic Sta… | The study was interrupted early and terminated when only 26 out of 80 patients were enrolled
due to new clinical study results indicating that the current study would not be informative. This study was interrupted early and terminated when only 26 out of 80 patients were enrolled. The patients were followed for 2 years rather than the planned 5 years. | |||
| NCT04158830 Details | 2020-11-13 Interventional | 4 | [7 Refs] | 0 | Aspirin Pre-Eclampsia Preeclampsia | PI is no longer at this University. - | ||
| NCT00796107 Details | 2020-11-13 Interventional | 2 | 6 | Letrozole Breast Neoplasm… Breast Cancer | Due to the discontinuation of compound development, this study has been terminated. Phase 2 of this study was not conducted. | |||
| NCT02897830 Details | 2020-11-12 Interventional | 2 | 46 | Dexamethasone Ixazomib Lenalidomide Multiple Myelom… Neoplasms, Plas… | negatives results - | |||
| NCT01925378 Details | 2020-11-12 Interventional | 2 | 0 | Nelfinavir Uterine Cervica… Cervical Dyspla… | The study is going to open in a new site - | |||
| NCT03037580 Details | 2020-11-10 Interventional | 3 | 84 | Treprostinil Heart Failure Hypertension Hypertension, P… Heart Failure W… Pulmonary Hyper… | Terminated by sponsor - | |||
| NCT04183634 Details | 2020-11-09 Interventional | 1 | 31 | Rotigotine Parkinson Disea… | Company Decision - | |||
| NCT04364815 Details | 2020-11-06 Interventional | 3 | 0 | Hydroxychloroqu… COVID-19 | Investigators opted to change the design of the study. - |